Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment

OBJECTIVES: Early evaluation of the effect of treatment is helpful in the management of cancer patients. Circulating biomarkers are an ideal tool for this if they are highly specific to tumors and respond rapidly to tumor volume changes. Circulating tumor DNA (ctDNA) is one such candidate. We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Fumio, Uchida, Junji, Kukita, Yoji, Kumagai, Toru, Nishino, Kazumi, Inoue, Takako, Kimura, Madoka, Kato, Kikuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342122/
https://www.ncbi.nlm.nih.gov/pubmed/27708242
http://dx.doi.org/10.18632/oncotarget.12373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342122/
https://www.ncbi.nlm.nih.gov/pubmed/27708242
http://dx.doi.org/10.18632/oncotarget.12373

Ejemplares similares